Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Dec 2024 for HLS Therapeutics Inc., €4,590.
Filing timeline
BuySaleJohn Lee Welborn Jr.
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
John Lee Welborn Jr.: trading record in brief
John Lee Welborn Jr. is a declared insider of HLS Therapeutics Inc., with filings sourced from SEDI. In total, 3 filings cover trades dated from 18 June 2021 to 12 December 2024.
Purchases make up the whole of the open-market record (2 purchases, €294k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2024, the count stands at 1 purchase and no sales.
Most recently, on 16 December 2024, the filings show an open-market purchase worth €4,590 in HLS Therapeutics Inc. The median gap between a trade and its publication by SEDI is 4 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John Lee Welborn Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
2,100 shares@ CA$3.251.6% of flowCommon SharesTSXSEDI:4418705
Canonical exit: 12 Mar 2025 (T+90)
Common SharesTSXSEDI:4142952
97,000 shares@ CA$4.30100.0% of flowCommon SharesTSXSEDI:4142957
Canonical exit: 6 Sept 2023 (T+90)
3 of 3 declarations
